Novel corneal phenotype in a patient with alport syndrome

Cornea

Volumn 28, Issue 5, 2009, Pages 599-606

  Bower, Kraig S ^a   Edwards, Jayson D ^a   Wagner, Melvin E ^a   Ward, Thomas P ^b   Hidayat, Ahmed ^c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Consulting Ophthalmologists PC ^*  (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Alport syndrome; Confocal microscopy; Corneal dystrophy; PPMD; Ultrastructure

Indexed keywords

CYTOKERATIN;

ADULT; ALPORT SYNDROME; ANAMNESIS; ARTICLE; CASE REPORT; CATARACT; CATARACT EXTRACTION; CLINICAL FEATURE; CONFOCAL MICROSCOPY; CORNEA CELL; CORNEA DYSTROPHY; CORNEA NECROSIS; CORNEA OPACITY; CORNEA STROMA; DESCEMET MEMBRANE; DESMOSOME; DNA POLYMORPHISM; ENDOTHELIUM CELL; FEMALE; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LENS IMPLANTATION; LENSECTOMY; MICROSCOPY; MICROVILLUS; OPHTHALMOSCOPY; PENETRATING KERATOPLASTY; PHENOTYPE; POSTERIOR POLYMORPHOUS DYSTROPHY; PRIORITY JOURNAL; SLIT LAMP; TRANSMISSION ELECTRON MICROSCOPY; VISUAL ACUITY; VISUAL IMPAIRMENT;

COLLAGEN TYPE IV; CORNEAL DYSTROPHIES, HEREDITARY; CORNEAL STROMA; CORNEAL TOPOGRAPHY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; MIDDLE AGED; NEPHRITIS, HEREDITARY; PHENOTYPE; POLYMORPHISM, GENETIC; VISUAL ACUITY;

EID: 67650613986     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31818f9706     Document Type: Article

References (43)

1. Alport AC. Hereditary familial congenital hemorrhagic nephritis. Br Med J. 1927;1:504-506.
2. Sohar E. Renal disease, inner ear deafness, and ocular changes: a new heredofamilial syndrome. AMA Arch Intern Med. 1956;97:627-630.
3. Colville DJ, Savige J. Alport syndrome. A review of the ocular manifestations. Ophthalmic Genet. 1997;18:161-173.
4. Jacobs M, Jeffrey B, Kriss A, et al. Ophthalmologic assessment of young patients with Alport syndrome. Ophthalmology. 1992;99: 1039-1044.
5. Nakanishi K, Iijima K, Kuroda N, et al. Comparison of alpha5(IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome. J Am Soc Nephrol. 1998;9:1433-1440.
6. Colville D, Savige J, Morfis M, et al. Ocular manifestations of autosomal recessive Alport syndrome. Ophthalmic Genet. 1997;18:119-128.
7. Kashtan CE. Alport syndrome. In: Massry SG, Glassock RJ, eds. Massry & Glassock's Textbook of Nephrology. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:850-855.
8. Atkin CL, Hasstedt SJ, Menlov L, et al. Mapping of Alport Syndrome to the long arm of the X chromosome. Am J Hum Genet. 1988;42: 249-255.
9. Barker DF, Hostikka SL, Zhou J, et al. Identification of mutations in the COL4A5 collagen gene in Alport Syndrome. Science. 1990;248: 1224-1227.
10. Faggioni R, Scouras J, Streiff EB. Alport's syndrome: clinicopathological considerations. Ophthalmologica. 1972;165:1-14.
11. Gubler M, Levy M, Broyer M, et al. Alport's syndrome. A report of 58 cases and a review of the literature. Am J Med. 1981;70:493-505.
12. Govan JA. Ocular manifestations of Alport's syndrome: a hereditary disorder of basement membranes? Br J Ophthalmol. 1983;67:493-503.
13. Thompson SM, Deady JP, Willshaw HE, et al. Ocular signs in Alport's syndrome. Eye. 1987;l(pt 1):146-153.
14. Gelisken O, Hendrikse F, Schroder CH, et al. Retinal abnormalities in Alport's syndrome. Acta Ophthalmol (Copenh). 1988;66:713-717.
15. Sabates R, Krachmer JH, Weingeist TA. Ocular findings in Alport's syndrome. Ophthalmologica. 1983;186:204-210.
16. Teekhasaenee C, Nimmanit S, Wutthiphan S, et al. Posterior polymorphous dystrophy and Alport syndrome. Ophthalmology. 1991;98: 1207-1215.
17. Chiou AG, Kaufman SC, Beuerman RW, et al. Confocal microscopy in posterior polymorphous corneal dystrophy. Ophthalmologica. 1999;213: 211-213.
18. Grupcheva CN, Chew GS, Edwards M, et al. Imaging posterior polymorphous corneal dystrophy by in vivo confocal microscopy. Clin Experiment Ophthalmol. 2001;29:256-259.
19. Cheng LL, Young AL, Wong AK, et al. Confocal microscopy of posterior polymorphous endothelial dystrophy. Cornea. 2005;24:599-602.
20. Patel DV, Grupcheva CN, McGhee CN. In vivo confocal microscopy of posterior polymorphous dystrophy. Cornea. 2005;24:550-554.
21. Ross JR, Foulks GN, Sanfilippo FP, et al. Immunohistochemical analysis of the pathogenesis of posterior polymorphous dystrophy. Arch Ophthalmol. 1995;113:340-345.
22. Cockerham GC, Laver NV, Hidayat AA, et al. An immunohistochemical analysis and comparison of posterior polymorphous dystrophy with congenital hereditary endothelial dystrophy. Cornea. 2002;21:787-791.
23. Laganowski HC, Sherrard ES, Muir MG. The posterior corneal surface in posterior polymorphous dystrophy: a specular microscopical study. Cornea. 1991;10:224-232.
24. Tripathi RC, Casey TA, Wise G. Hereditary posterior polymorphous dystrophy: an ultrastructural and clinical report. Trans Ophthal Soc UK. 1974;94:211-225.
25. Johnson BL, Brown SI. Posterior polymorphous dystrophy: a light and electron microscopic study. Br J Ophthalmol. 1978;62:89-96.
26. Dagher H, Yan Wang Y, Fassett R, et al. Three novel COL4A4 mutations resulting in stop codons and their clinical effects in autosomal recessive Alport syndrome.Hum Mutat. 2002;20:321-322.
27. Buzza M, Dagher H, Wang YY, et al. Mutations in the COL4A4 gene in thin basement membrane disease. Kidney Int. 2003;63:447-453.
28. Nielsen CE. Lenticonus anterior and Alport's syndrome. Acta Ophthalmol (Copenh). 1978;56:518-530.
29. Makkar RP, Arora A, Monga A, et al. Alport's syndrome with blue sclera. J Assoc Physicians India. 2003;51:510-511.
30. Davies PD. Pigment dispersion in a case of Alport's syndrome. Br J Ophthalmol. 1970;54:557-561.
31. Amari F, Segawa K, Ando F Lens coloboma and Alport-like glomerulonephritis. Eur J Ophthalmol. 1994;4:181-183.
32. Cervantes-Coste G, Fuentes-Paez G, Yeshurun I, et al. Tapetal-like sheen associated with fleck retinopathy in Alport syndrome. Retina. 2003;23: 245-247.
33. Yasuzumi K, Futagami S, Kiyosawa M, et al. Bilateral serous retinal detachment associated with Alport's syndrome. Ophthalmologica. 2000; 214:301-304.
34. Mete UO, Karaaslan C, Ozbilgin MK, et al. Alport's syndrome with bilateral macular hole. Acta Ophthalmol Scand. 1996;74:77-80.
35. Friedburg D. [Pseudoneuritis and drusen of the optic disk in Alport's syndrome]. Klin Monatsbl Augenheilkd. 1968;152:379-383.
36. Rhys C, Snyers B, Pirson Y Recurrent corneal erosion associated with Alport's syndrome. Rapid communication. Kidney Int. 1997;52:208-211.
37. Cibis GW, Krachmer JH, Phelps CD, et al. The clinical spectrum of posterior polymorphous dystrophy. Arch Ophthalmol. 1977;95:1529-1537.
38. Waring GO, Rodrigues MM, Laibson PR. Corneal dystrophies. II. Endothelial dystrophies. Surv Ophthalmol. 1978;23:147-168.
39. Rodrigues MM, Sun TT, Krachmer J, et al. Epithelialization of the corneal endothelium in posterior polymorphous dystrophy. Invest Ophthalmol Vis Sci. 1980;19:832-835.
40. Peterson WS, Albert DM. Fundus changes in the hereditary nephropathies. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:762-771.
41. Burke JP, Clearkin LG, Talbot JF Recurrent corneal epithelial erosions in Alport's syndrome. Acta Ophthalmol (Copenh). 1991;69:555-557.
42. Nishida T. Cornea. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea, Fundamentals of Cornea and External Disease, Vol 1. Philadelphia, PA: Elsevier; 2005:3-26.
43. Varga JH, Rubinfeld RS, Wolf TC, et al. Topical anesthetic abuse ring keratitis: report of four cases. Cornea. 1997;16:424-429.